OmniAb (OABI) Receivables - Other (2023 - 2026)
OmniAb (OABI) reported Receivables - Other of $3.5 million for Q1 2026, up 400.0% year-over-year from $700000.0 in Q1 2025, and up 337.5% quarter-over-quarter from $800000.0 in Q4 2025.
OmniAb (OABI) Receivables - Other (2023 - 2026) Analysis & Trends
OmniAb (OABI) has 4 years of Receivables - Other data on file, last reported at $3.5 million in Q1 2026.
- Receivables - Other for Q1 2026 came in at $3.5 million, up 400.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 400.0% YoY), and the FY2025 annual result was $800000.0, down 69.23% from the prior year.
- Receivables - Other advanced to $3.5 million in Q1 2026 per OABI's latest filing, from $800000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $3.5 million in Q1 2026 and troughed at $300000.0 in Q3 2025.
- A 4-year average of $1.3 million and a median of $800000.0 in 2023 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2025 and 2026: Receivables - Other sank 69.23% in 2025, then surged 400.0% in 2026.
- A 4-year view of Receivables - Other shows it stood at $800000.0 in 2023, then soared by 225.0% to $2.6 million in 2024, then slumped by 69.23% to $800000.0 in 2025, then soared by 337.5% to $3.5 million in 2026.
- Business Quant data shows OABI's Receivables - Other at $3.5 million in Q1 2026, $800000.0 in Q4 2025, and $300000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | OmniAb | 294.96 Mn | 252.00 Mn | 14.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.50 Mn |
| Mar 31, 2026 | 3.50 Mn |
| Dec 31, 2025 | 800,000.00 |
| Dec 31, 2025 | 800,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Sep 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |